Artane Dosage

The usual starting Artane dosage for the treatment of Parkinson's disease is 1 mg once daily. If needed, your healthcare provider can increase your dose up to 15 mg daily to control your symptoms. For treating extrapyramidal symptoms, the recommended Artane dose is also 1 mg daily. If symptoms do not improve within a few hours, your healthcare provider may increase your dosage as necessary.

Artane Dosage: An Introduction

The dose of Artane® (trihexyphenidyl hydrochloride) that your healthcare provider recommends will vary, depending on a number of factors, including:
 
  • How you respond to Artane (especially if you develop side effects)
  • The medical condition being treated
  • Other medications you are taking
  • Other medical conditions you may have.
     
As is always the case, do not adjust your dose unless your healthcare provider specifically instructs you to do so.
 

Artane Dosing for Parkinson's Disease

The usual starting Artane dosage for treating Parkinson's disease is 1 mg once daily. Your healthcare provider may gradually increase your dose (by increments of 2 mg every three to five days) until your symptoms are controlled or up to a maximum of 15 mg total per day. Usually, it is recommended that the daily Artane dose be split up into three smaller doses taken at meals, or if higher doses are taken (more than 10 mg total per day), into four smaller doses per day, at meals and at bedtime.
 
Be aware that lower doses are often necessary when Artane is combined with levodopa products (such as Sinemet®, Sinemet® CR, Parcopa®, or Stalevo®).
7 Tricks to Relieve Your Enlarged Prostate

Artane Drug Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.